Advanced Search

 

Study ID Status Title Patient Level Data
107737 Completed Study to assess the safety and immunogenicity of GSK Biologicals 10-valent pneumococcal conjugate vaccine when Co-administered with DTPa-HBV-IPV/Hib (Infanrix-Hexa) vaccine in preterm infants as a 3-dose primary immunization course during the first 6 months of life. Study Listed on ClinicalStudyDataRequest.com
107806 Completed An open label study to determine the safety, tolerability, excretion balance and pharmacokinetics of [14C]GW856553, administered as a single dose of an oral solution to healthy adult male subjects.
107824 Completed A study to evaluate the long-term antibody persistence at 1, 3 & 5 years after the administration of a fourth dose of Hib-MenCY-TT Vaccine compared to ActHIB in subjects boosted in a previous study. Study Listed on ClinicalStudyDataRequest.com
107863 Completed Evaluation of the safety and immunogenicity of GlaxoSmithKline Biologicals' HPV vaccine 580299 (Cervarix TM) in adult human immunodeficiency virus (HIV) infected female subjects Study Listed on ClinicalStudyDataRequest.com
107876 Completed Study to evaluate clinical consistency of the liquid formulation of GSK Biologicals' HRV vaccine and to evaluate liquid formulation compared to lyophilised formulation of the HRV vaccine administered as a two-dose primary vaccination. Study Listed on ClinicalStudyDataRequest.com
107924 Completed Open, booster vaccination study to assess safety and reactogenicity of GSK Biologicals’ dTpa vaccine (Boostrix) when administered to healthy chinese children 6-8 years of age. Study Listed on ClinicalStudyDataRequest.com
107979 Completed TXA107979: A Randomized, Multicenter, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of a Combination Product Containing Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine in Adolescents Study Listed on ClinicalStudyDataRequest.com
107988 Completed A Dose Rising Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Oral Doses of the Enteric-Coated Free Base Formulation of SB-480848 in Healthy Adult Subjects
108134 Completed A study to demonstrate the efficacy of GSK Biologicals’ influenza vaccine (Fluarix™) administered intramuscularly in adults Study Listed on ClinicalStudyDataRequest.com
108251 Completed Evaluate immunogenicity & safety of a single or double-dose of the pandemic influenza candidate vaccine (GSK1562902A) given following a two-administration schedule (21 days apart) in adults over 60 yrs Study Listed on ClinicalStudyDataRequest.com
108251 Completed Evaluate immunogenicity & safety of a single or double-dose of the pandemic influenza candidate vaccine (GSK1562902A) given following a two-administration schedule (21 days apart) in adults over 60 yrs Study Listed on ClinicalStudyDataRequest.com
108251 Completed Evaluate immunogenicity & safety of a single or double-dose of the pandemic influenza candidate vaccine (GSK1562902A) given following a two-administration schedule (21 days apart) in adults over 60 yrs Study Listed on ClinicalStudyDataRequest.com
108366 Completed An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Simvastatin When Coadministered With Albiglutide in Healthy Adult Subjects Study Listed on ClinicalStudyDataRequest.com
108370 Completed An adaptive design study for the assessment of the pharmacokinetics of albiglutide in subjects with normal renal function and subjects with moderate-to-severe renal impairment and hemodialysis. Study Listed on ClinicalStudyDataRequest.com
108372 Completed A single-site, randomized, double-blind, placebo-controlled, parallel-group, stepped glucose clamp study to assess the effects of albiglutide on counter-regulatory hormone responses and recovery from hypoglycemia in subjects with Type 2 diabetes mellitus. Study Listed on ClinicalStudyDataRequest.com
108392 Completed An open-label, multi-centre rollover study to assess the safety and efficacy of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligible to initiate antiviral therapy (peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin)
108414 Completed A placebo-controlled, single blind, randomized two part study toinvestigate the tolerability, pharmacokinetics, and brainDopamine D3 receptor occupancy of increasing repeat doses ofGSK618334 for up to 21 days in healthy volunteers. Study Listed on ClinicalStudyDataRequest.com
108464 Completed A multicentre study to evaluate the immunogenicity and safety of GSK Biologicals’ HPV vaccine (580299) Co-administered with Boostrix Polio (dTpa-IPV) in healthy female subjects aged 10–18 years Study Listed on ClinicalStudyDataRequest.com
108486 Completed A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared with the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
108504 Completed An open label, single dose, randomised, parallel group pharmacokinetic study to evaluate a combination product containing naproxen sodium and sumatriptan in adolescent subjects with migraine and healthy adult subjects administered at three doses. Study Listed on ClinicalStudyDataRequest.com
108556 Completed A Multicenter, Randomized, Single-Dose, Double-Blind, Cross-Over Study to Evaluate Patient Preference of GW685698X Aqueous Nasal Spray and PAR Fluticasone Propionate in Subjects with Allergic Rhinitis Study Listed on ClinicalStudyDataRequest.com
108638 Completed Immunogenicity and safety study of GlaxoSmithKline (GSK) Biologicals’ Boostrix (dTpa) vaccine and the Chinese DT vaccine, when administered as booster vaccination in healthy children aged 6-8 years Study Listed on ClinicalStudyDataRequest.com
108760 Completed Immunogenicity & safety study of GSK Biologicals’ 208136 vaccine formulated with new measles and rubella working seeds Study Listed on ClinicalStudyDataRequest.com
108844 Active not recruiting Study VEG108844, A study of Pazopanib versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma
108844 Active not recruiting Study VEG108844, A study of Pazopanib versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.